Company Filing History:
Years Active: 2024
Title: Arjun Prasanna Athreya: Innovator in Clinical Analytics
Introduction
Arjun Prasanna Athreya is a notable inventor based in Urbana, IL (US). He has made significant contributions to the field of clinical analytics, particularly in the realm of mental health. His work focuses on leveraging data to improve treatment outcomes for psychological conditions.
Latest Patents
Arjun holds a patent for an "Analytics and machine learning framework for actionable intelligence from clinical and omics data." This innovative framework provides methods for accurately predicting the dynamics of symptom response to drugs or other interventions for the treatment of major depressive disorder and other psychological conditions. The methods allow for a reduction in the time required to evaluate the effectiveness of therapeutic interventions. By utilizing measured and self-reported symptom severity at multiple time points, the framework classifies symptoms into categories such as low, moderate, and severe. These classifications are then applied to predictive models to forecast symptom progression and treatment efficacy. The methods can be enhanced with metabolomics and genomics data, enabling a more objective approach to diagnosing and treating psychological conditions.
Career Highlights
Arjun Prasanna Athreya is affiliated with the University of Illinois, where he continues to advance his research and innovations. His work is pivotal in bridging the gap between subjective assessments and objective physiological measures in mental health treatment.
Collaborations
Arjun collaborates with esteemed colleagues, including Ravishankar Krishnan Iyer and Richard Merle Weinshilboum. Their combined expertise contributes to the development of innovative solutions in clinical analytics.
Conclusion
Arjun Prasanna Athreya is a pioneering inventor whose work in analytics and machine learning is transforming the landscape of mental health treatment. His contributions are vital for improving patient outcomes and advancing the field of clinical research.